← All trials
NCT04880148
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 3, 2021
- Primary completion
- Jun 1, 2024
- Completion date
- Sep 1, 2024
- First posted
- May 10, 2021
- Last posted
- Nov 5, 2021
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Cyprus University of TechnologyLead sponsor
- Cyprus University of TechnologyReponsible party - principal investigator
- Cyprus University of TechnologyOverall official - principal investigator
- German Oncology Center, CyprusCollaborator
- Bank of Cyprus Oncology CentreCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.